Analyst Consensus ?
ConsensusBuy37 ratings
Bullish2875.7%
Neutral924.3%
Bearish00.0%
Newmont Corporation · NEM · FY2024 Q4 · Calendar Q1 2025
Newmont’s portfolio reset raises execution questions
The supplied analysis supports a constructive but conditional view: portfolio simplification, productivity, project development, and resilient gold demand provide potential support, while cost, leverage, permitting, and execution risks limit confidence.
Reported After market closeNYSEBasic Materials
$124.35B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $1.11
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $5.34B
Revenue surprise
—
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
-5.7%
Event window
SPY move
-1.7%
Same window
Abnormal move
-4.0%
Stock minus SPY
Volume
1.8×
Versus trailing sessions
Subsequent drift
+4.5%
Up to 20 sessions
NEMSPY benchmark
Ask FN2 about NEM FY2024 Q4
Transcript, numbers and history already loaded
What drove NEM's -5.7% move after FY2024 Q4 earnings?What changed in NEM's guidance and outlook in FY2024 Q4?Give me the bull and bear case for NEM after FY2024 Q4 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
The analysis emphasizes that the divestiture program is nearly complete and that management is shifting attention toward Tier 1 asset execution, project development, productivity, and capital allocation.
Guidance delta
Management guidance was maintained.
Key takeaways
- Management emphasized a stronger portfolio after non-core asset divestitures.
- The operating outlook rests on gold demand, Tier 1 assets, productivity, and project development.
- Capital allocation remains focused on shareholder returns, debt reduction, and strategic capital spending.
Management priorities
- Advance Cadia, Lihir, Red Chris, Yanacocha, Tanami, and Ahafo North projects.
- Continue productivity and cost-reduction initiatives across the core portfolio.
- Maintain focus on capital allocation, safety, and integration execution.
Follow NEM with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$118.01Previous close
$57Low
$107.5Average
$175High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 20, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| RBC Capital | Outperform | Outperform | Maintain | Sep 16, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Sep 9, 2026 |
| Scotiabank | Sector Outperform | Sector Outperform | Maintain | Aug 12, 2026 |
| Barclays | Overweight | Overweight | Maintain | Jul 28, 2026 |
| TD Cowen | Buy | Hold | Upgrade | Jul 14, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 9, 2026 |
| Jefferies | Buy | Buy | Maintain | Jul 6, 2026 |
| UBS | Buy | Buy | Maintain | Jun 30, 2026 |
| BMO Capital | Outperform | Outperform | Maintain | Apr 24, 2026 |
| CIBC | Outperform | Outperform | Maintain | Apr 21, 2026 |
| Citigroup | Buy | Buy | Maintain | Mar 3, 2026 |
| Freedom Broker | Buy | Buy | Maintain | Sep 30, 2025 |
| Raymond James | Outperform | Outperform | Maintain | Sep 23, 2025 |
| Macquarie | Neutral | Outperform | Downgrade | Sep 2, 2025 |
| JP Morgan | Overweight | Neutral | Upgrade | Nov 19, 2024 |
| Argus Research | Buy | Hold | Upgrade | Aug 29, 2024 |
| TD Securities | Hold | Hold | Maintain | Apr 29, 2024 |
| Goldman Sachs | Buy | Buy | Maintain | Apr 21, 2023 |
| Canaccord Genuity | Buy | Hold | Upgrade | Mar 14, 2023 |
| Exane BNP Paribas | Outperform | Neutral | Upgrade | Feb 13, 2023 |
| Credit Suisse | Neutral | Outperform | Downgrade | Apr 19, 2022 |
| Deutsche Bank | Buy | Buy | Maintain | Jun 17, 2020 |
| B. Riley Securities | Buy | Buy | Maintain | May 19, 2020 |
| B. Riley FBR | Buy | Buy | Maintain | May 19, 2020 |
| B. Riley | Buy | Neutral | Upgrade | Jan 13, 2020 |
| Citi | Buy | Neutral | Upgrade | May 23, 2019 |
| Morgan Stanley | Overweight | Equal Weight | Upgrade | Jun 12, 2018 |
| Argus | Hold | Buy | Downgrade | May 5, 2018 |
| Bank of America | Buy | Buy | Maintain | Feb 26, 2018 |
| Standpoint Research | Buy | Hold | Upgrade | Dec 29, 2016 |
| Mackie Research | Buy | Hold | Upgrade | Oct 31, 2016 |
| Clarksons Platou | Neutral | Buy | Downgrade | Apr 18, 2016 |
| Clarkson Capital Markets | Neutral | Buy | Downgrade | Apr 18, 2016 |
| FBR Capital | Market Perform | Market Perform | Maintain | Jan 28, 2016 |
| HSBC | Hold | Buy | Downgrade | Oct 26, 2015 |
| BB&T Capital | Hold | Buy | Downgrade | Nov 3, 2014 |
| Cowen & Co. | Outperform | Market Perform | Upgrade | Sep 9, 2014 |
Named analyst price targets
Upside is calculated against the persisted previous close $118.01. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Barclays | Analyst unavailable | $123 | $118.6 | +4.2% | Oct 19, 2026 |
| CIBC | Analyst unavailable | $154 | $119.56 | +30.5% | Oct 16, 2026 |
| Bernstein | Analyst unavailable | $144 | $127.09 | +22.0% | Sep 9, 2026 |
| Raymond James | Brian MacArthur | $140 | $130.96 | +18.6% | Aug 24, 2026 |
| CIBC | Analyst unavailable | $170 | $117.85 | +44.1% | Aug 14, 2026 |
| Scotiabank | Analyst unavailable | $149 | $119.62 | +26.3% | Aug 12, 2026 |
| Argus Research | Alexandra Yates | $110 | $93.87 | -6.8% | Aug 3, 2026 |
| CIBC | Anita Soni | $168 | $91.64 | +42.4% | Jul 28, 2026 |
| Barclays | Richard Garchitorena | $124 | $93.47 | +5.1% | Jul 28, 2026 |
| Barclays | Analyst unavailable | $125 | $95.04 | +5.9% | Jul 15, 2026 |
| Scotiabank | Analyst unavailable | $147 | $94.88 | +24.6% | Jul 14, 2026 |
| RBC Capital | Josh Wolfson | $135 | $94.52 | +14.4% | Jul 9, 2026 |
| Jefferies | Analyst unavailable | $146 | $97.04 | +23.7% | Jul 6, 2026 |
| UBS | Analyst unavailable | $120 | $92.34 | +1.7% | Jun 30, 2026 |
| CIBC | Anita Soni | $175 | $107.23 | +48.3% | Jun 1, 2026 |
| Barclays | Analyst unavailable | $133 | $108.33 | +12.7% | May 21, 2026 |
| TD Securities | Steven Green | $129 | $120.7 | +9.3% | Apr 27, 2026 |
| BMO Capital | Matthew Murphy | $145 | $117.87 | +22.9% | Apr 24, 2026 |
| CIBC | Anita Soni | $176 | $110.51 | +49.1% | Apr 21, 2026 |
| National Bank | Shane Nagle | $130 | $113.41 | +10.2% | Apr 16, 2026 |
| UBS | Analyst unavailable | $140 | $102.1 | +18.6% | Mar 27, 2026 |
| BMO Capital | Matthew Murphy | $140 | $121.02 | +18.6% | Feb 20, 2026 |
| Stifel Nicolaus | Analyst unavailable | $175 | $120.39 | +48.3% | Feb 10, 2026 |
| CIBC | Analyst unavailable | $177 | $114.36 | +50.0% | Feb 4, 2026 |
| UBS | Analyst unavailable | $160 | $117.25 | +35.6% | Jan 30, 2026 |
| Scotiabank | Analyst unavailable | $152 | $128.69 | +28.8% | Jan 26, 2026 |
| Raymond James | Analyst unavailable | $111 | $100.47 | -5.9% | Dec 29, 2025 |
| Jefferies | Fahad Tariq | $120 | $89.76 | +1.7% | Dec 7, 2025 |
| BNP Paribas | Analyst unavailable | $97 | $90.72 | -17.8% | Dec 5, 2025 |
| UBS | Daniel Major | $125 | $91.82 | +5.9% | Dec 1, 2025 |
| Raymond James | Brian MacArthur | $99 | $83.31 | -16.1% | Oct 24, 2025 |
| Scotiabank | Analyst unavailable | $114 | $87.01 | -3.4% | Oct 23, 2025 |
| UBS | Analyst unavailable | $105.5 | $93.58 | -10.6% | Oct 16, 2025 |
| Goldman Sachs | Analyst unavailable | $104.3 | $85.14 | -11.6% | Oct 12, 2025 |
| Raymond James | Brian MacArthur | $96 | $85.21 | -18.7% | Oct 10, 2025 |
| CIBC | Analyst unavailable | $112 | $85.21 | -5.1% | Oct 10, 2025 |
| RBC Capital | Josh Wolfson | $95 | $75.92 | -19.5% | Sep 9, 2025 |
| Macquarie | Andrew Bowler | $72 | $74.4 | -39.0% | Sep 1, 2025 |
| CIBC | Anita Soni | $74 | $57.35 | -37.3% | Jul 15, 2025 |
| Argus Research | John Eade | $63 | $53.68 | -46.6% | Apr 25, 2025 |
| Raymond James | Analyst unavailable | $66 | $53.94 | -44.1% | Apr 25, 2025 |
| UBS | Daniel Major | $54 | $47.8 | -54.2% | Oct 30, 2024 |
| RBC Capital | Josh Wolfson | $53 | $57.74 | -55.1% | Oct 24, 2024 |
| Jefferies | Matthew Murphy | $63 | $53.04 | -46.6% | Oct 4, 2024 |
| Jefferies | Matthew Murphy | $54 | $51.3 | -54.2% | Sep 10, 2024 |
| Argus Research | John Eade | $58 | $51.83 | -50.9% | Aug 29, 2024 |
| Scotiabank | Tanya Jakusconek | $59 | $51.19 | -50.0% | Aug 19, 2024 |
| BMO Capital | Jackie Przybylowski | $57 | $47.7 | -51.7% | Jul 25, 2024 |
| CIBC | Anita Soni | $61 | $45.36 | -48.3% | Jul 10, 2024 |
| UBS | Daniel Major | $50 | $40.97 | -57.6% | Jun 17, 2024 |
| Scotiabank | Tanya Jakusconek | $48 | $41.28 | -59.3% | May 23, 2024 |
| Goldman Sachs | Emily Chieng | $67 | $41.02 | -43.2% | Dec 15, 2023 |
| RBC Capital | Josh Wolfson | $60 | $45.61 | -49.2% | Jul 27, 2022 |
| Canaccord Genuity | Carey MacRury | $60 | $46.14 | -49.2% | Jul 26, 2022 |
| Canaccord Genuity | Analyst unavailable | $80 | $73.43 | -32.2% | Apr 26, 2022 |
| Fundamental Research | Siddharth Rajeev | $63.1 | $55.25 | -46.5% | Nov 8, 2021 |
| CIBC | Anita Soni | $69 | $53.09 | -41.5% | Oct 29, 2021 |
| TD Securities | Greg Barnes | $70 | $58.82 | -40.7% | Jul 26, 2021 |
| Desjardins | John Sclodnick | $85.94 | $71.39 | -27.2% | May 20, 2021 |
| Argus Research | David Coleman | $73 | $62.68 | -38.1% | May 5, 2021 |
| BMO Capital | Andrew Kaip | $85 | $60.33 | -28.0% | Apr 30, 2021 |
Track every rating change on NEM the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationNewmont Corporation is primarily involved in the mining and exploration of gold resources. Additionally, the company undertakes prospecting for other base and precious metals, including copper, silver, zinc, and lead. Its operations and assets are geographically widespread, located across various countries such as the United States, Canada, Mexico, the Dominican Republic, Peru, Suriname, Argentina, Chile, Australia, and Ghana. As of the close of 2021 (December 31st), Newmont reported substantial proven and probable gold reserves, totaling 92.8 million ounces, and managed a vast land portfolio covering 62,800 square kilometers. Founded in 1916, the company's corporate headquarters are situated in Denver, Colorado.
Historical context
All NEM earningsBasic Materials peers this season
Latest reports in the same sector| Company | Quarter | EPS surprise | Market move | Headline |
|---|---|---|---|---|
| AA Alcoa Corporation | FY2026 Q3 · Calendar Q4 2026 | +20.5% | +7.2% | Alcoa: Strong Q3 execution, with safety and transaction risks ahead |
Latest beats and misses
Who reports nextBeat on EPS
Missed on EPS
Get the NEM recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2025-02-06T00:01:56.136176+00:00
- Polygon adjusted daily market bars · 2026-10-20T11:20:41.038239+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-20T11:20:41.035383+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-20. For educational purposes only; not investment advice.